Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease

Background:  It has been hypothesised, mainly from studies with animal models of liver disease, that the transport of substrates for metabolic enzymes and their subsequent metabolism and elimination in hepatic bile or blood is co‐ordinated, but there is little information on this process in diseased human liver.

[1]  P. Kochanek,et al.  The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity. , 1998, Research communications in molecular pathology and pharmacology.

[2]  T. A. Richardson,et al.  Regulation of drug-metabolizing enzymes and transporters in inflammation. , 2006, Annual review of pharmacology and toxicology.

[3]  Ning Li,et al.  Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. , 2004, Molecular pharmacology.

[4]  Hong-Yang Wang,et al.  Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. , 2003, World journal of gastroenterology.

[5]  S. Kliewer,et al.  Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. , 2002, Molecular pharmacology.

[6]  C. Abbott,et al.  Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. , 2002, The American journal of pathology.

[7]  B. Blumberg,et al.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.

[8]  K. Bock,et al.  Coordinate Regulation of Drug Metabolism by Xenobiotic Nuclear Receptors: UGTs Acting Together with CYPs and Glucuronide Transporters , 2004, Drug metabolism reviews.

[9]  T. Roskams,et al.  Expression and regulation of ABC transporter genes during liver regeneration , 2018 .

[10]  R. Levine,et al.  AST/ALT Ratio ≥1 Is Not Diagnostic of Cirrhosis in Patients with Chronic Hepatitis C , 1998, Digestive Diseases and Sciences.

[11]  P. Meier,et al.  Coordinate transcriptional regulation of transport and metabolism. , 2005, Methods in enzymology.

[12]  Ping Wang,et al.  Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis , 2004, Critical care medicine.

[13]  Xingguo Cheng,et al.  Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine , 2006, Drug Metabolism and Disposition.

[14]  P. Desmond,et al.  UDP glucuronosyltransferase mRNA levels in human liver disease. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[15]  Mi-Sook Kim,et al.  Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[16]  J. Pascussi,et al.  Interleukin 1β inhibits CAR‐induced expression of hepatic genes involved in drug and bilirubin clearance , 2004, Hepatology.

[17]  P. Mackenzie,et al.  UDP glucuronosyltransferase in the cirrhotic rat liver , 1996, Journal of gastroenterology and hepatology.

[18]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[19]  J. Danks,et al.  Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury. , 1995, Gastroenterology.

[20]  P. Mackenzie,et al.  Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4&agr; , 2007, Pharmacogenetics and genomics.

[21]  K. Koike,et al.  Interaction of hepatitis C virus core protein with retinoid X receptor α modulates its transcriptional activity , 2002, Hepatology.

[22]  K. Renton.  Cytochrome P450 regulation and drug biotransformation during inflammation and infection. , 2004, Current drug metabolism.

[23]  F. Sanai,et al.  Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection? , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[24]  E. Morgan.  Regulation of cytochrome p450 by inflammatory mediators: why and how? , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[25]  G. Crabtree,et al.  A transcriptional hierarchy involved in mammalian cell-type specification , 1992, Nature.

[26]  M. Negishi,et al.  INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS , 2006, Drug Metabolism and Disposition.

[27]  R. Thrall,et al.  The cytochromes P450 (CYP) response to allergic inflammation of the lung. , 2006, Archives of biochemistry and biophysics.

[28]  J. Knight,et al.  Liver Function Tests: Their Role in the Diagnosis of Hepatobiliary Diseases , 2005, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[29]  K. Byth,et al.  Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. , 1995, Biochemical pharmacology.

[30]  G. Siest,et al.  Genetic Polymorphism of CYP2C19 Gene in the Stanislas Cohort. A link with Inflammation , 2008, Annals of human genetics.

[31]  C. McClain,et al.  Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. , 1994, The Journal of clinical investigation.

[32]  K. Sugimachi,et al.  Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. , 2001, Journal of hepatology.

[33]  Olivier Fardel,et al.  Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.

[34]  Jeremy J. W. Chen,et al.  Differential gene expression in gram-negative and gram-positive sepsis. , 2004, American journal of respiratory and critical care medicine.

[35]  P. Heinrich,et al.  Hepatic cytochrome P450 down‐regulation during aseptic inflammation in the mouse is interleukin 6 dependent , 2000, Hepatology.

[36]  M. Ingelman-Sundberg,et al.  Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. , 2004, Biochemical pharmacology.

[37]  M. Wortham,et al.  Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver , 2007, Drug Metabolism and Disposition.